131 related articles for article (PubMed ID: 31298363)
1. Physcion 8-O-β-glucopyranoside exhibits anti-growth and anti-metastatic activities in ovarian cancer by downregulating miR-25.
Xue CL; Liu HG; Li BY; He SH; Yue QF
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5101-5112. PubMed ID: 31298363
[TBL] [Abstract][Full Text] [Related]
2. Involvement of NORAD/miR-608/STAT3 axis in carcinostasis effects of physcion 8-O-β-glucopyranoside on ovarian cancer cells.
Yang X; Yan Y; Chen Y; Li J; Yang J
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2855-2865. PubMed ID: 31299866
[TBL] [Abstract][Full Text] [Related]
3. Anti-proliferative of physcion 8-O-β-glucopyranoside isolated from Rumex japonicus Houtt. on A549 cell lines via inducing apoptosis and cell cycle arrest.
Xie QC; Yang YP
BMC Complement Altern Med; 2014 Oct; 14():377. PubMed ID: 25283233
[TBL] [Abstract][Full Text] [Related]
4. Physcion 8-O-β-glucopyranoside induces mitochondria-dependent apoptosis of human oral squamous cell carcinoma cells via suppressing survivin expression.
Liu MD; Xiong SJ; Tan F; Liu Y
Acta Pharmacol Sin; 2016 May; 37(5):687-97. PubMed ID: 27063218
[TBL] [Abstract][Full Text] [Related]
5. Physcion 8-O-β-glucopyranoside exhibits anti-leukemic activity through targeting sphingolipid rheostat.
Han J; Zhao P; Shao W; Wang Z; Wang F; Sheng L
Pharmacol Rep; 2018 Oct; 70(5):853-862. PubMed ID: 30092415
[TBL] [Abstract][Full Text] [Related]
6. Physcion-8-O-β-d-glucoside interferes with the nuclear factor-κB pathway and downregulates P-glycoprotein expression to reduce paclitaxel resistance in ovarian cancer cells.
Li X; He Y; Wei L; Zhang J; Li X; Cui W; Zhang S
J Pharm Pharmacol; 2021 Mar; 73(4):545-552. PubMed ID: 33793827
[TBL] [Abstract][Full Text] [Related]
7. Physcion 8-O-β-Glucopyranoside Exerts Anti-Tumor Activity Against Non-Small Cell Lung Cancer by Targeting PPARγ.
Du Y; Lv Z; Sun D; Li Y; Sun L; Zhou J
Anat Rec (Hoboken); 2019 May; 302(5):785-793. PubMed ID: 30312015
[TBL] [Abstract][Full Text] [Related]
8. Berbamine suppresses cell proliferation and promotes apoptosis in ovarian cancer partially via the inhibition of Wnt/β-catenin signaling.
Zhang H; Jiao Y; Shi C; Song X; Chang Y; Ren Y; Shi X
Acta Biochim Biophys Sin (Shanghai); 2018 Jun; 50(6):532-539. PubMed ID: 29701777
[TBL] [Abstract][Full Text] [Related]
9. Physcion 8-O-β-glucopyranoside suppresses the metastasis of breast cancer in vitro and in vivo by modulating DNMT1.
Chen X; Guo H; Li F; Fan D
Pharmacol Rep; 2017 Feb; 69(1):36-44. PubMed ID: 27768961
[TBL] [Abstract][Full Text] [Related]
10. Emodin inhibits TGF-β2 by activating the FOXD3/miR‑199a axis in ovarian cancer cells in vitro.
Song K; Lv T; Chen Y; Diao Y; Yao Q; Wang Y
Oncol Rep; 2018 May; 39(5):2063-2070. PubMed ID: 29512773
[TBL] [Abstract][Full Text] [Related]
11. Ligustrazine inhibits the proliferation and migration of ovarian cancer cells via regulating miR-211.
Zhang H; Ding S; Xia L
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33245099
[TBL] [Abstract][Full Text] [Related]
12. miR-144 Potentially Suppresses Proliferation and Migration of Ovarian Cancer Cells by Targeting RUNX1.
Han S; Zhu J; Zhang Y
Med Sci Monit Basic Res; 2018 Feb; 24():40-46. PubMed ID: 29445078
[TBL] [Abstract][Full Text] [Related]
13. Effects of microRNA-1271 on ovarian cancer via inhibition of epithelial-mesenchymal transition and cisplatin resistance.
Chen Y; Wang L; Zhou J
J Obstet Gynaecol Res; 2019 Nov; 45(11):2243-2254. PubMed ID: 31411791
[TBL] [Abstract][Full Text] [Related]
14. Physcion inhibits the metastatic potential of human colorectal cancer SW620 cells in vitro by suppressing the transcription factor SOX2.
Han YT; Chen XH; Gao H; Ye JL; Wang CB
Acta Pharmacol Sin; 2016 Feb; 37(2):264-75. PubMed ID: 26707141
[TBL] [Abstract][Full Text] [Related]
15. Chikusetsusaponin IVa methyl ester induces G1 cell cycle arrest, triggers apoptosis and inhibits migration and invasion in ovarian cancer cells.
Chen X; Wu QS; Meng FC; Tang ZH; Chen X; Lin LG; Chen P; Qiang WA; Wang YT; Zhang QW; Lu JJ
Phytomedicine; 2016 Dec; 23(13):1555-1565. PubMed ID: 27823619
[TBL] [Abstract][Full Text] [Related]
16. Physcion 8-O-β-glucopyranoside exerts carcinostasis ability in Ishikawa cells via regulating lnc-SLC4A1-1/H3K27ac/NF-κB pathway.
Yang L
Pharmazie; 2020 Jul; 75(7):348-352. PubMed ID: 32635979
[TBL] [Abstract][Full Text] [Related]
17. Metformin inhibits human breast cancer cell growth by promoting apoptosis via a ROS-independent pathway involving mitochondrial dysfunction: pivotal role of superoxide dismutase (SOD).
Sharma P; Kumar S
Cell Oncol (Dordr); 2018 Dec; 41(6):637-650. PubMed ID: 30088260
[TBL] [Abstract][Full Text] [Related]
18. Physcion, a naturally occurring anthraquinone derivative, induces apoptosis and autophagy in human nasopharyngeal carcinoma.
Pang MJ; Yang Z; Zhang XL; Liu ZF; Fan J; Zhang HY
Acta Pharmacol Sin; 2016 Dec; 37(12):1623-1640. PubMed ID: 27694907
[TBL] [Abstract][Full Text] [Related]
19. Piceatannol-3-O-β-D-glucopyranoside (PG) exhibits in vitro anti-metastatic and anti-angiogenic activities in HT1080 malignant fibrosarcoma cells.
Kim A; Ma JY
Phytomedicine; 2019 Apr; 57():95-104. PubMed ID: 30668328
[TBL] [Abstract][Full Text] [Related]
20. MiR-203a-3p regulates the biological behaviors of ovarian cancer cells through mediating the Akt/GSK-3β/Snail signaling pathway by targeting ATM.
Liu HY; Zhang YY; Zhu BL; Feng FZ; Zhang HT; Yan H; Zhou B
J Ovarian Res; 2019 Jul; 12(1):60. PubMed ID: 31277702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
